Search for: "GLAXOSMITHKLINE INC."
Results 1 - 20
of 355
Sort by Relevance
|
Sort by Date
29 Apr 2024, 4:15 am
However, GSK contends their competitors, Pfizer Inc. and Pharmacia & Upjohn Co. [read post]
29 Apr 2024, 4:15 am
However, GSK contends their competitors, Pfizer Inc. and Pharmacia & Upjohn Co. [read post]
5 Mar 2024, 10:55 am
For example, GlaxoSmithKline will only automatically issue refunds to covered entities that are owed an aggregate refund of $100 or more; all covered entities that are owed less than $100 must contact GlaxoSmithKline to request a refund. [read post]
28 Feb 2024, 2:00 pm
Kirby Inland Marine Inc. (5th Cir. 2007) 482 F.3d 347, 351.) [read post]
19 Jan 2024, 4:00 am
In other contexts, there have been concerns that double patenting may increase burdens under the Notice of Compliance regime for pharmaceuticals – see for example, Glaxosmithkline Inc. v Apotex Inc, 2003 FCT 687 at 90: “The existence of additional patents allows the patent-holder to bring additional applications, thereby obtaining multiple injunctive periods. [read post]
18 Jan 2024, 9:16 am
The Federal Circuit explicitly limited its holding in GlaxoSmithKline LLC v. [read post]
18 Dec 2023, 10:00 pm
USA, Inc. , 7 F.4th 1320 (Fed. [read post]
18 Dec 2023, 9:07 pm
Mylan Pharmaceuticals Inc. [read post]
7 Dec 2023, 1:47 pm
Teva Pharmaceuticals USA, Inc., 7 F.4th 1320, 1333 (Fed. [read post]
22 Nov 2023, 10:36 am
Hectronic International, Inc. (2023), the Supreme Court held that federal statutes should be presumed to apply only to conduct in the United States unless those statutes clearly indicate that they apply extraterritorially. [read post]
21 Jul 2023, 11:56 am
GlaxoSmithKline, 905 F.3d 694, 707 (3d Cir. 2018) that such an inquiry is fact-specific and requires the consideration of multiple factors. [read post]
18 May 2023, 8:01 am
Most surprisingly to me, the court denied review in Teva Pharmaceuticals USA, Inc. v. [read post]
15 May 2023, 10:14 am
USA, Inc. v. [read post]
15 May 2023, 7:21 am
GlaxoSmithKline LLC. [read post]
11 May 2023, 1:16 pm
GlaxoSmithKline LLC. [read post]
1 May 2023, 10:11 am
Teva Pharmaceuticals USA, Inc. v. [read post]
21 Jan 2023, 6:07 pm
Steven Nissen, on the supposed risk of heart attack from the use of rosiglitazone (Avandia).[2] Within days, lawsuits were filed against the manufacturer, GlaxoSmithKline, which ultimately paid over six billion dollars in settlements and costs.[3] Only after the harm of this mass tort was largely complete, the results of a mega-trial, RECORD,[4] became available, and the FDA changed its regulatory stance on rosiglitazone.[5] More recently, on October 17, 2022, the Journal of the National… [read post]
22 Dec 2022, 10:14 am
Further, therein, it is reported that GlaxoSmithKline Inc. has updated the Canadian product monograph for Valtrex to add information about the risk of Valtrex-associated DRESS. [read post]
22 Dec 2022, 7:59 am
Apple Inc., et al. v. [read post]
17 Oct 2022, 11:27 am
” Ravgen, Inc. v. [read post]
